Valuation : Tong Ren Tang Technologies Co. Ltd.

Market Cap 3.53B 525M 451M 422M 387M 728M 50.17B 730M 5B 1.95B 25.28B 1.97B 1.93B 83.68B P/E 2026 *
7.77x
P/E 2027 * 6.89x
Enterprise Value 3.53B 525M 451M 422M 387M 728M 50.17B 730M 5B 1.95B 25.28B 1.97B 1.93B 83.68B EV / Sales 2026 *
0.51x
EV / Sales 2027 * 0.47x
Free-Float
45.7%
Yield 2026 *
5.8%
Yield 2027 * 6.53%
07-09 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective July 9, 2026 CI
06-29 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
06-29 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
06-12 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
05-26 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
04-27 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
03-30 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
03-27 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
03-27 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-26 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
02-06 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
01-13 Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Li Siu Bun from the Positions as an Independent Non-Executive Director, Chairman of the Audit Committee of the Board and A Member of Each of the Remuneration Committee of the Board and the Strategy and Planning Committee CI
12-30 Tong Ren Tang Technologies Co. Ltd. Announces Board Changes CI
1 day-5.36%
1 week-7.02%
Current month-8.09%
1 month-14.05%
3 months-15.43%
6 months-30.57%
Current year-31.76%
1 week 0.32
Extreme 0.318
0.34
1 month 0.31
Extreme 0.312
0.38
Current year 0.31
Extreme 0.312
0.5
1 year 0.31
Extreme 0.312
0.55
3 years 0.31
Extreme 0.312
0.8
5 years 0.31
Extreme 0.312
1.02
10 years 0.31
Extreme 0.312
1.3
Manager TitleAgeSince
Chief Executive Officer 58 03/06/2025
Comptroller/Controller/Auditor 48 03/06/2025
Corporate Secretary 37 08/07/2026
Director TitleAgeSince
Director/Board Member 67 09/02/2011
Director/Board Member 69 11/06/2018
Director/Board Member 82 11/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
-5.36%-7.02% - - 534M
+1.01%+1.01%-13.78%-5.57% 13.34B
+1.98%+0.33%-35.14%-57.05% 4.99B
+1.85%-5.05%-6.75%-2.34% 4.63B
+1.58%-4.23%-1.29%-28.74% 3.99B
+1.01%+0.61%-21.17%+5.44% 3.62B
+2.21%+3.87%-6.13%-3.71% 3.43B
-0.47%-4.16%-13.69%+11.83% 3.28B
+0.86%-3.04%-19.63%-15.55% 2.43B
+1.82%-1.23%-31.46%-11.34% 1.71B
Average +0.65%-1.10%-16.56%-11.89% 4.6B
Weighted average by Cap. +1.20%-0.81%-15.44%-11.97%

Financials

2026 *2027 *
Net sales 6.98B 1.04B 892M 835M 764M 1.44B 99.21B 1.44B 9.89B 3.86B 50B 3.9B 3.82B 165B 7.56B 1.13B 966M 904M 828M 1.56B 107B 1.56B 10.71B 4.19B 54.16B 4.22B 4.13B 179B
Net income 454M 67.62M 58.05M 54.34M 49.76M 93.74M 6.46B 94.01M 644M 252M 3.25B 254M 248M 10.77B 514M 76.4M 65.58M 61.4M 56.22M 106M 7.3B 106M 727M 284M 3.68B 287M 281M 12.17B
Net Debt - -
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,951
Date Price Change
27/08/26 €0.3320 -1.19%
26/08/26 €0.3360 +2.44%
25/08/26 €0.3280 -0.61%
24/08/26 €0.3300 +1.85%
21/08/26 €0.3240 -5.26%
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.757CNY
Average target price
4.601CNY
Spread / Average Target
+66.91%

Annual profits - Rate of surprise